Fatal rhabdomyolysis and multiple organ failure associated with adjuvant high-dose interferon alfa in malignant melanoma
- 1 February 1997
- journal article
- Published by Elsevier in The Lancet
- Vol. 349 (9051) , 540-541
- https://doi.org/10.1016/s0140-6736(97)80091-8
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.Journal of Clinical Oncology, 1996
- Acute rhabdomyolysis after concurrent administration of interleukin-2, interferon-alfa, and chemotherapy for metastatic melanomaCancer, 1995
- Drug Points: Rhabdomyolysis after treatment with interferon alfaBMJ, 1994